Idorsia Ltd ( IDRSF) - Key Metrics
IDRSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.19 | -$0.31 | ? | ? |
| 2025Q3 | $0.19 | -$0.40 | -$0.10 | -$0.10 |
| 2025Q2 | $0.35 | -$0.06 | -$0.17 | -$0.22 |
| 2025Q1 | $0.31 | $0.33 | -$0.32 | -$0.32 |
IDRSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.39 |
| 2025Q3 | ? | -2.70 |
| 2025Q2 | ? | -9.63 |
| 2025Q1 | ? | 0.76 |
IDRSF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -3.42% | ? |
| 2025Q4 | -4.47% | ? |
| 2025Q3 | -2.66% | ? |
| 2025Q2 | -12.52% | ? |
| 2025Q1 | -34.71% | ? |
IDRSF
Price: $5.75
52 week price:
Earnings Per Share: -1.31 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion